Back to Market Feed

Product Information

DOFETILIDE 125 MCG CAPSULE is a generic product labeled by Sigmapharm Laboratories LLC, priced at $0.1997 per EA under NDC 42794004410. Its NADAC has been published 415 times since Sep 12, 2018.

FDA first approved this application on Mar 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOFETILIDE 125 MCG CAPSULE

Dofetilide
$0.1997per EA

Strength

125 ug/1

NDC

42794004410

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOFETILIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207746

FDA Approved

3/26/2018

TE Code

AB

On Market Since

6/11/2018

Pharmacological Classes

Antiarrhythmic

Price Statistics

The NADAC for DOFETILIDE 125 MCG CAPSULE has been published 415 times since Sep 12, 2018, and over the history we have for it it has declined 95.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1997 per EA
All-time high$4.6718 (Sep 12, 2018)
All-time low$0.1776 (May 22, 2024)
52-week high$0.2198
52-week low$0.1925
Median price$0.6852
Average price$1.1765
Largest weekly change+110.6% (Jan 18, 2023)
Weeks tracked415
Tracking sinceSep 12, 2018

Price History

1W

-0.1%

1M

-0.1%

3M

-2.4%

6M

+3.7%

1Y

-9.0%

3Y

-59.5%

5Y

-77.1%

All

-95.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dofetilide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0280
per GM
GNP LIDOCAINE HCL 4% CREAM
Generic
46122061410•AmerisourceBergen
$0.0517
per GM
LIDOCAINE HCL 4% CREAM
Generic
70000009801•Cardinal Health
$0.0517
per GM
LIDOCAINE HCL 1% VIAL
Generic
00409427602•Hospira Inc.
$0.0542
per ML
LIDOCAINE HCL 2% VIAL
Generic
00409427702•Hospira Inc.
$0.0569
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016300•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016330•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% VIAL
Generic
00143957710•Hikma Pharmaceuticals USA Inc.
$0.0694
per ML
LIDOCAINE HCL 1% VIAL
Generic
00409427601•Hospira Inc.
$0.0694
per ML

Frequently asked questions

What is the NADAC price of DOFETILIDE 125 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 125 MCG CAPSULE, manufactured by Sigmapharm Laboratories LLC, is $0.1997 per EA (NDC 42794004410), effective Aug 19, 2026.

How has the price of DOFETILIDE 125 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOFETILIDE 125 MCG CAPSULE has declined 95.7%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for DOFETILIDE 125 MCG CAPSULE?

Since Sep 12, 2018, the NADAC for DOFETILIDE 125 MCG CAPSULE has ranged from a low of $0.1776 (May 22, 2024) to a high of $4.6718 (Sep 12, 2018), with a median of $0.6852 per EA.

Are there cheaper alternatives to DOFETILIDE 125 MCG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DOFETILIDE 125 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DOFETILIDE 125 MCG CAPSULE?

DOFETILIDE 125 MCG CAPSULE (NDC 42794004410) is labeled by Sigmapharm Laboratories LLC, and CMS classifies it as a generic product.